Sastasundar Ventures Limited (SASTASUNDR.NS)
INR 252.95
(0.09%)
INR 252.95
(0.09%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 | -203.51 Million INR | 80.93% |
| 2023 | -1.06 Billion INR | -113.33% |
| 2022 | 11.22 Billion INR | -290.84% |
| 2021 | -109.57 Million INR | 74.78% |
| 2020 | -518.92 Million INR | -38.69% |
| 2019 | -332.73 Million INR | -158.08% |
| 2018 | -60.56 Million INR | 30.95% |
| 2017 | -181.19 Million INR | 28.23% |
| 2016 | -285.53 Million INR | -155.96% |
| 2015 | -82.2 Million INR | -22.84% |
| 2014 | -43.09 Million INR | -165.92% |
| 2013 | 129.25 Million INR | -83.98% |
| 2012 | 861.71 Million INR | -30.51% |
| 2011 | 441.73 Million INR | 34.59% |
| 2010 | 921.31 Million INR | 79.88% |
| 2009 | 512.17 Million INR | -22.52% |
| 2008 | 661.01 Million INR | 129.49% |
| 2007 | 288.03 Million INR | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q4 | -18.73 Million INR | -66.83% |
| 2024 Q3 | 164.59 Million INR | 80.09% |
| 2024 Q2 | 158.54 Million INR | -38.79% |
| 2024 FY | - INR | 143.28% |
| 2024 Q1 | 157.46 Million INR | 174.09% |
| 2023 Q4 | -300.36 Million INR | 1.1% |
| 2023 Q2 | -251.71 Million INR | -18.97% |
| 2023 Q1 | -211.57 Million INR | 15.67% |
| 2023 FY | - INR | -113.33% |
| 2023 Q3 | -303.7 Million INR | -20.65% |
| 2022 Q2 | -74.42 Million INR | -1.29% |
| 2022 Q4 | -250.88 Million INR | -147.18% |
| 2022 FY | - INR | -290.84% |
| 2022 Q1 | -73.47 Million INR | -48.01% |
| 2022 Q3 | -101.5 Million INR | -36.39% |
| 2021 Q3 | -39.78 Million INR | -27.16% |
| 2021 FY | - INR | 74.78% |
| 2021 Q4 | -49.64 Million INR | -24.79% |
| 2021 Q2 | -31.28 Million INR | -328.72% |
| 2021 Q1 | -7.29 Million INR | 94.24% |
| 2020 FY | - INR | -38.69% |
| 2020 Q1 | -139.8 Million INR | 15.95% |
| 2020 Q2 | -124.29 Million INR | 11.1% |
| 2020 Q3 | -114.71 Million INR | 7.7% |
| 2020 Q4 | -126.72 Million INR | -10.46% |
| 2019 Q2 | -57.2 Million INR | 8.28% |
| 2019 Q3 | -79.98 Million INR | -39.83% |
| 2019 FY | - INR | -158.08% |
| 2019 Q1 | -62.36 Million INR | -37.4% |
| 2019 Q4 | -166.33 Million INR | -107.96% |
| 2018 Q1 | -46.81 Million INR | -22.55% |
| 2018 Q4 | -45.39 Million INR | -587.31% |
| 2018 FY | - INR | 30.95% |
| 2018 Q3 | -6.6 Million INR | 72.1% |
| 2018 Q2 | -23.66 Million INR | 49.45% |
| 2017 Q4 | -38.2 Million INR | 26.32% |
| 2017 FY | - INR | 28.23% |
| 2017 Q1 | -63.22 Million INR | 35.97% |
| 2017 Q2 | -28.98 Million INR | 54.15% |
| 2017 Q3 | -51.84 Million INR | -78.87% |
| 2016 Q1 | -40.68 Million INR | 32.8% |
| 2016 FY | - INR | -155.96% |
| 2016 Q4 | -98.73 Million INR | -28.15% |
| 2016 Q3 | -77.04 Million INR | -11.52% |
| 2016 Q2 | -69.08 Million INR | -69.82% |
| 2015 FY | - INR | -22.84% |
| 2015 Q4 | -60.53 Million INR | -716.73% |
| 2015 Q3 | -7.41 Million INR | 27.4% |
| 2015 Q2 | -10.21 Million INR | -43.48% |
| 2015 Q1 | -7.11 Million INR | 90.45% |
| 2014 FY | - INR | -165.92% |
| 2014 Q4 | -74.49 Million INR | -785.31% |
| 2014 Q3 | -8.41 Million INR | -10238.55% |
| 2014 Q2 | 83 Thousand INR | 101.57% |
| 2014 Q1 | -5.29 Million INR | 98.6% |
| 2013 Q3 | 160.99 Million INR | -15.15% |
| 2013 FY | - INR | -83.98% |
| 2013 Q1 | 168.79 Million INR | 0.0% |
| 2013 Q2 | 189.73 Million INR | 12.41% |
| 2013 Q4 | -378.91 Million INR | -335.36% |
| 2012 Q2 | - INR | 0.0% |
| 2012 Q1 | - INR | 0.0% |
| 2012 FY | - INR | -30.51% |
| 2011 FY | - INR | 34.59% |
| 2010 FY | - INR | 79.88% |
| 2009 FY | - INR | -22.52% |
| 2008 FY | - INR | 129.49% |
| 2007 FY | - INR | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| MedPlus Health Services Limited | 3.94 Billion INR | 105.164% |